CSIMarket
 


Celcuity Inc   (CELC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

CELC's Net Cash Flow Growth by Quarter and Year

Celcuity Inc 's Net Cash Flow results by quarter and year




CELC Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -32.91 -6.08 -2.06
III Quarter September - -9.43 48.73 -1.73
II Quarter June -1.40 -11.38 6.70 -1.42
I Quarter March 9.07 -5.99 23.30 -1.88
FY   7.67 -59.71 72.65 -7.09



CELC Net Cash Flow second quarter 2023 Y/Y Growth Comment
Celcuity Inc in the second quarter 2023 recorded net cash outflow of $ -1.40 millions.

Looking into second quarter 2023 results within Medical Laboratories industry 2 other companies have achieved higher Net Cash Flow growth. While Celcuity Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 359 in the second quarter 2023.




CELC Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Celcuity Inc 's second quarter 2023 Net Cash Flow $ -1.40 millions CELC's Income Statement
Celcuity Inc 's second quarter 2022 Net Cash Flow $ -11.38 millions Quarterly CELC's Income Statement
New: More CELC's historic Net Cash Flow Growth >>


CELC Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - 627.31 % -
II Quarter June - - -71.24 % -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #66
Overall #359

Net Cash Flow Y/Y Growth Statistics
High Average Low
139.78 % -104.84 % -237.19 %
(Mar 31 2022)   (Jun 30 2023)
Net Cash Flow second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #66
Overall #359
Net Cash Flow Y/Y Growth Statistics
High Average Low
139.78 % -104.84 % -237.19 %
(Mar 31 2022)   (Jun 30 2023)

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Celcuity Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CELC's II. Quarter Q/Q Net Cash Flow Comment
Current accomplishment of -1.40 millions by Celcuity Inc appear even worse if you take a look at 9.07 millions net cash outflow in the first quarter.

Within Medical Laboratories industry Celcuity Inc achieved highest sequential Net Cash Flow growth. While Celcuity Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CELC's II. Quarter Q/Q Net Cash Flow Comment
Recent net cash outflow of -1.40 millions by Celcuity Inc come out even less good if you take a look at 9.07 millions a quarter before.

Within Medical Laboratories industry Celcuity Inc achieved highest sequential Net Cash Flow growth. While Celcuity Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Celcuity Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Net Cash Flow 12 Months Ending $ -34.67 $ -44.66 $ -59.71 $ -32.88 $ 25.27
Y / Y Net Cash Flow Growth (TTM) - - - - -3.57 %
Year on Year Net Cash Flow Growth Overall Ranking # 295 # 211 # 0 # 0 # 224
Seqeuential Net Cash Flow Change (TTM) - - - - -41.71 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 359 # 405 # 0 # 0 # 830




Cumulative Net Cash Flow growth Comment
Celcuity Inc realized trailing twelve months net cash outflow of $ -35 millions, in the Jun 30 2023, compare to Net Cash Flow of $ 25 millions a year ago.

In the Healthcare sector 55 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 211 to 295.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
139.78 %
-104.84 %
-237.19 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 3
Healthcare Sector # 56
Overall # 295

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
139.78 %
-104.84 %
-237.19 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 66
S&P 500 # 359
Cumulative Net Cash Flow growth Comment
Celcuity Inc realized trailing twelve months net cash outflow of $ -35 millions, in the Jun 30 2023, compare to Net Cash Flow of $ 25 millions a year ago.

In the Healthcare sector 55 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 211 to 295.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
139.78 %
-104.84 %
-237.19 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 3
Healthcare Sector # 56
Overall # 295

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
139.78 %
-104.84 %
-237.19 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 66
S&P 500 # 359




Other Net Cash Flow Growth
Medical Laboratories Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
CELC's Net Cash Flow Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for CELC's Competitors
Net Cash Flow Growth for Celcuity Inc 's Suppliers
Net Cash Flow Growth for CELC's Customers

You may also want to know
CELC's Annual Growth Rates CELC's Profitability Ratios CELC's Asset Turnover Ratio CELC's Dividend Growth
CELC's Roe CELC's Valuation Ratios CELC's Financial Strength Ratios CELC's Dividend Payout Ratio
CELC's Roa CELC's Inventory Turnover Ratio CELC's Growth Rates CELC's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Jun 30 2023
Spruce Biosciences Inc -1.28%$ -1.282 millions
Progyny Inc -4.14%$ -4.142 millions
Stereotaxis Inc -6.01%$ -6.013 millions
Catalyst Pharmaceuticals Inc -6.15%$ -6.146 millions
Cardiff Lexington Corporation-13.04%$ -13.036 millions
Lifevantage Corp-13.28%$ -13.283 millions
Abbvie inc -15.48%$ -15.477 millions
Avita Medical Inc -15.78%$ -15.781 millions
Tenon Medical Inc -16.42%$ -16.417 millions
Sensus Healthcare Inc -18.33%$ -18.328 millions
Cyteir Therapeutics Inc -19.66%$ -19.660 millions
Qrons Inc -20.11%$ -20.111 millions
Cutera Inc -20.16%$ -20.164 millions
Collegium Pharmaceutical Inc -20.31%$ -20.313 millions
Harrow Inc -21.92%$ -21.915 millions
Vertex Pharmaceuticals Inc-22.03%$ -22.025 millions
Dynavax Technologies Corporation-24.67%$ -24.671 millions
Arcellx Inc -27.49%$ -27.491 millions
Applied Therapeutics inc -27.49%$ -27.492 millions
Standard Biotools Inc -35.46%$ -35.461 millions
Royalty Pharma Plc-37.64%$ -37.638 millions
Horizon Therapeutics Public Limited Company-38.80%$ -38.803 millions
Cohbar Inc -39.13%$ -39.128 millions
Fonar Corporation-39.55%$ -39.551 millions
Tenaya Therapeutics Inc -39.60%$ -39.603 millions
Endra Life Sciences Inc -40.63%$ -40.631 millions
Tarsus Pharmaceuticals Inc -42.04%$ -42.041 millions
Cassava Sciences Inc-42.94%$ -42.941 millions
Lemaitre Vascular Inc -46.23%$ -46.232 millions
Omeros Corp-46.38%$ -46.375 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com